Thu 26 Nov 2009 | 5:30 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For OSI Pharmaceuticals, Inc.

OSI Pharmaceuticals, Inc. (OSIP.O) (Nasdaq)
sector: Healthcare . industry: Biotechnology ยท View OSIP on other exchanges
As of  25 Nov 2009
33.00USD
Price Change
-0.07
Percent Change
-0.21%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Wood, Barbara 47 2007 Senior Vice President, General Counsel, Secretary
Amper, Linda 52 2007 Senior Vice President - Human Resources
Lundemose, Anker 47 2005 Executive Vice President; President of OSI Prosidion; CEO of Prosidion
Leung, Gabriel 47 2005 Executive Vice President; President - (OSI) Oncology Business
Simon, Robert 64 2007 Executive Vice President - Pharmaceutical Development and Manufacturing
White, John 62 1985 Director
Mehta, Viren 59 1999 Director
Pinedo, Herbert 63 2004 Director
Stevenson, Katharine 47 2005 Director
Costa, Santo 63 2006 Director
Klein, Joseph 48 2006 Director
Niemiec, David 60 2006 Director
Lee, Kenneth 61 2007 Director
Legault, Pierre 48 2008 Chief Financial Officer, Executive Vice President, Treasurer
Goddard, Colin 49 2003 Chief Executive Officer, Director
Ingram, Robert 66 2003 Chairman of the Board